BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10037834)

  • 1. [Efficacy of F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) scans in diagnosis of pulmonary nodules].
    Orino K; Kawamura M; Hatazawa J; Suzuki I; Sazawa Y
    Jpn J Thorac Cardiovasc Surg; 1998 Dec; 46(12):1267-74. PubMed ID: 10037834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
    Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
    Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.
    Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
    Lung Cancer; 2004 Jul; 45(1):19-27. PubMed ID: 15196730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
    Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I
    J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
    Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
    JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is
    Lee SH; Sung C; Lee HS; Yoon HY; Kim SJ; Oh JS; Song JW; Kim MY; Ryu JS
    Ann Nucl Med; 2018 Aug; 32(7):492-498. PubMed ID: 29974372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography.
    Purandare NC; Pramesh CS; Agarwal JP; Agrawal A; Shah S; Prabhash K; Karimundackal G; Jiwnani S; Tandon S; Rangarajan V
    Indian J Cancer; 2017; 54(1):271-275. PubMed ID: 29199704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
    AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules.
    Fortes DL; Allen MS; Lowe VJ; Shen KR; Wigle DA; Cassivi SD; Nichols FC; Deschamps C
    Eur J Cardiothorac Surg; 2008 Dec; 34(6):1223-7. PubMed ID: 18848459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis.
    Dewan NA; Reeb SD; Gupta NC; Gobar LS; Scott WJ
    Chest; 1995 Aug; 108(2):441-6. PubMed ID: 7634881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of radiographically indeterminate solitary pulmonary nodules with.
    Hung GU; Shiau YC; Tsai SC; Ho YJ; Kao CH; Yen RF
    Jpn J Clin Oncol; 2001 Feb; 31(2):51-4. PubMed ID: 11302341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of sodium iodide based (18)F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses.
    Pitman AG; Hicks RJ; Binns DS; Ware RE; Kalff V; McKenzie AF; Ball DL; MacManus MP
    Br J Radiol; 2002 Feb; 75(890):114-21. PubMed ID: 11893634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
    Deppen S; Putnam JB; Andrade G; Speroff T; Nesbitt JC; Lambright ES; Massion PP; Walker R; Grogan EL
    Ann Thorac Surg; 2011 Aug; 92(2):428-32; discussion 433. PubMed ID: 21592456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial evaluation of pulmonary abnormalities: CT-guided fine-needle aspiration biopsy and fluoride-18 fluorodeoxyglucose positron emission tomography correlation.
    Collins BT; Lowe VJ; Dunphy FR
    Diagn Cytopathol; 2000 Feb; 22(2):92-6. PubMed ID: 10649518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
    Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
    Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions.
    Gupta N; Gill H; Graeber G; Bishop H; Hurst J; Stephens T
    Chest; 1998 Oct; 114(4):1105-11. PubMed ID: 9792584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.